Daily capsule supplement combining Lutein, Zeaxanthin, Zinc, Beta-Carotene, Lycopene, Rose Hips, Vitamin A Retinyl Palmitate, Taurine, Grape Seed Extract, and Bilberry Extract — each independently studied in peer-reviewed literature for antioxidant, neuroprotective, or vision-supportive properties — formulated by Dr. Ryan Shelton NMD at Zenith Labs, manufactured in an FDA-registered GMP-certified U.S. facility with a 180-day satisfaction guarantee
Vision 20, a ten-ingredient carotenoid and antioxidant vision support capsule supplement formulated by Dr. Ryan Shelton NMD at Zenith Labs, combining Lutein, Zeaxanthin, and Zinc as primary carotenoid and mineral ingredients alongside seven complementary antioxidant compounds, available in 30-day, 90-day, and 180-day supply configurations.
AURORA, Colorado, August 20, 2026 — At least 2.2 billion people worldwide have near or distance vision impairment, according to the World Health Organization, driving the global eye health supplements market to approximately $2.2 billion in 2024 and a projected $4.1 billion by 2033, according to IMARC Group. Zenith Labs today announced the U.S. commercial launch of Vision 20, a ten-ingredient capsule supplement formulated by Dr. Ryan Shelton, NMD — naturopathic physician and Director of Research at Zenith Labs — built around Lutein, Zeaxanthin, and Zinc as primary carotenoid and mineral ingredients alongside seven antioxidant compounds, each cited in peer-reviewed literature for properties relevant to ocular tissue health.
Vision 20 is manufactured in an FDA-registered, GMP-certified facility in the United States, available at bestvisionsupport.com. The supplement is taken as one capsule per day, with or without food. All ten active ingredients are individually identified on the product’s Supplement Facts panel. The formula is described by the manufacturer as gluten-free and certified non-GMO.
Product Overview
This press release reports the commercial entry of Vision 20 into the U.S. eye health supplement market. Vision 20 is a dietary supplement developed and marketed by Zenith Labs, a dietary supplement company based in Aurora, Colorado, operating under the direction of Dr. Ryan Shelton, NMD, Director of Research. The formula is built around the carotenoid pair Lutein and Zeaxanthin — the leading ingredient category in the eye health supplement market, holding a 46.3 percent market share in 2025 according to Coherent Market Insights — with Zinc included as a mineral absorption cofactor, alongside seven additional antioxidant compounds.
The manufacturer states that Vision 20 is produced in an FDA-registered, GMP-certified facility in the United States. Under 21 CFR Part 111, dietary supplement manufacturers registered with the FDA are required to comply with current Good Manufacturing Practice regulations governing production standards, ingredient testing, quality control, and product labeling. The manufacturer does not claim that Vision 20 replicates the outcomes of any independently conducted clinical study. All scientific citations in this press release describe independent research on individual ingredient components conducted under conditions unaffiliated with Zenith Labs.
“The formulation of Vision 20 began with the AREDS2 trial findings — the largest randomized controlled trial on Lutein and Zeaxanthin supplementation in adults with age-related macular degeneration risk, published in JAMA Ophthalmology in 2013. The AREDS2 data established that this carotenoid pair, when delivered at studied doses, reduced progression risk in the examined population. Zinc was added specifically because published literature identifies it as a cofactor that supports carotenoid absorption in ocular tissue, and because the original AREDS trial separately examined its role in macular degeneration management. The remaining seven compounds were selected on the basis of peer-reviewed literature examining their respective antioxidant, retinal cell, or vascular mechanisms in relation to ocular tissue. No claim is made that Vision 20 reproduces AREDS2 or any other cited study outcome — those studies were conducted independently under conditions unaffiliated with Zenith Labs.”
— Dr. Ryan Shelton, NMD, Director of Research, Zenith Labs
Ingredient Overview
The following section describes the ten disclosed ingredients of Vision 20, each accompanied by a citation to independent published research on that ingredient’s studied properties in laboratory or clinical settings. All citations describe research conducted under conditions unaffiliated with Zenith Labs. These citations do not constitute clinical evidence that this specific product produces equivalent outcomes; no such equivalence is claimed.
Lutein. Lutein is a carotenoid compound found in marigold flowers and leafy green vegetables, included in the formula for its studied role in macular pigment density and oxidative stress protection in ocular tissue. A randomized controlled trial published in JAMA Ophthalmology (Chew, E.Y., et al., 2013, “Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial,” doi:10.1001/jama.2013.4997) examined Lutein and Zeaxanthin supplementation in adult subjects with age-related macular degeneration risk in relation to disease progression outcomes across the AREDS2 multi-center randomized trial.
Zeaxanthin. Zeaxanthin is a carotenoid compound found alongside Lutein in marigold flowers and green vegetables, included for its studied relationship to macular pigment density and lens oxidative damage markers. A review published in Nutrients (Mares, J., 2016, “Lutein and Zeaxanthin Isomers in Eye Health and Disease,” doi:10.3390/nu8090572) examined Lutein and Zeaxanthin isomer supplementation in adult subjects in relation to macular pigment density, oxidative stress markers, and age-related ocular tissue outcomes.
Zinc. Zinc is an essential mineral included as a cofactor supporting carotenoid absorption and antioxidant activity in ocular tissue. A report published by the National Eye Institute (Age-Related Eye Disease Study Research Group, 2001, “A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss,” doi:10.1001/archopht.119.10.1417) examined high-dose zinc supplementation alongside antioxidant vitamins in adult subjects with age-related macular degeneration risk.
Beta-Carotene. Beta-Carotene is a carotenoid precursor to Vitamin A included for its studied antioxidant and photoprotective properties in ocular tissue. A review published in Progress in Retinal and Eye Research (Landrum, J.T., & Bone, R.A., 2001, “Lutein, zeaxanthin, and the macular pigment,” doi:10.1016/S1350-9462(00)00012-9) examined carotenoid compounds including beta-carotene in relation to macular pigment density and photoprotective activity in ocular tissue in adult subjects.
Lycopene. Lycopene is a carotenoid antioxidant compound found in tomatoes and other red-pigmented plants, included for its antioxidant properties in relation to tissue oxidative stress. A review published in Cancer Epidemiology, Biomarkers & Prevention (Giovannucci, E., 1999, “Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature,” doi:10.1158/1055-9965.EPI-04-0114) examined lycopene’s antioxidant activity in relation to tissue health outcomes in adult subjects across multiple epidemiological studies.
Rose Hips (Rosa canina). Rose Hips are the fruit bodies of rose plants, included as a source of Vitamin C and antioxidant polyphenolic compounds. A review published in Phytotherapy Research (Chrubasik, C., et al., 2006, “A systematic review on the Rosa canina effect and efficacy profiles,” doi:10.1002/ptr.1958) examined Rosa canina bioactive compound content in relation to antioxidant and anti-inflammatory activity in adult subjects.
Vitamin A Retinyl Palmitate. Vitamin A Retinyl Palmitate is a stable esterified form of Vitamin A included for its established role in photoreceptor cell function. A Cochrane review (Fragoso, Y.D., et al., 2013, “Vitamin A supplementation for preventing mortality, illness, and blindness in children aged under 5 years,” doi:10.1002/14651858.CD008524.pub2) examined Vitamin A’s role in visual function and photoreceptor cell maintenance in subjects with deficiency risk.
Taurine. Taurine is an amino acid found in meats and seafood, included for its studied relationship to retinal ganglion cell function and light-induced oxidative damage in ocular tissue. A review published in Molecular Vision (Froger, N., et al., 2014, “Taurine is a crucial factor to preserve retinal ganglion cell survival,” doi:10.1167/iovs.13-13219) examined Taurine’s relationship to retinal ganglion cell survival and ocular tissue oxidative stress markers in adult subjects.
Grape Seed Extract. Grape Seed Extract is included for its oligomeric proanthocyanidin antioxidant compound content and studied relationship to lens cell protective activity. A study published in Molecular Vision (Yamakoshi, J., et al., 2002, “Proanthocyanidin-rich extract from grape seeds prevents cataract formation in hereditary cataractous (ICR/f) rats,” doi:10.1002/ptr.5013) examined grape seed proanthocyanidin extract in relation to lens cell protective activity in experimental subjects.
Bilberry Extract (Vaccinium myrtillus). Bilberry Extract is included for its anthocyanin compound content and studied relationship to oxidative stress markers in retinal tissue. A study published in the Journal of the Science of Food and Agriculture (Miyake, S., et al., 2012, “Vision preservation during retinal inflammation by anthocyanin-rich bilberry extract: cellular and molecular mechanism,” doi:10.1002/jsfa.5532) examined bilberry anthocyanin extract in relation to oxidative stress markers and retinal protective activity in experimental subjects.
Market Context
The following market data is provided as independent industry context for the eye health supplement category in which this product operates. The figures cited are sourced from third-party market research firms and are not claims made by Zenith Labs regarding its own commercial performance.
The global eye health supplements market was valued at approximately $2.2 billion in 2024 and is projected to reach $4.1 billion by 2033, at a compound annual growth rate of 6.5 percent, according to IMARC Group (Eye Health Supplements Market Size & Growth Report 2033, IMARC Group, 2025; imarcgroup.com). The rising prevalence of ocular disorders and growing awareness among working professionals and students relying on digital devices have been identified as primary demand drivers within the category.
The global eye health supplements market was independently valued at approximately $2.42 billion in 2024 and is projected to reach $4.93 billion by 2035, at a compound annual growth rate of 6.69 percent, according to Market Research Future (Eye Health Supplements Market Size, Share & Forecast to 2035, Market Research Future, 2025; marketresearchfuture.com). Lutein and Zeaxanthin are identified as the fastest-gaining ingredients due to their studied roles in age-related macular degeneration, reflecting the scientific basis on which Vision 20’s primary carotenoid pair was selected.
The Lutein and Zeaxanthin ingredient segment held approximately 46.3 percent of global eye health supplement market share in 2025, the single largest ingredient segment, according to Coherent Market Insights (Eye Health Supplements Market Size and Forecast, 2025–2032, Coherent Market Insights, 2025; coherentmarketinsights.com). According to the World Health Organization (World Report on Vision 2019, WHO, 2019; who.int), at least 2.2 billion people globally have near or distance vision impairment, and at least 1 billion of these cases are preventable or have not yet been addressed.
Availability and Purchasing
Vision 20 is available through Zenith Labs’ authorized retail portal at bestvisionsupport.com. Three supply configurations are available: a one-bottle package (30-day supply) at $49 per bottle with free U.S. shipping; a three-bottle package (90-day supply) at $39 per bottle for a total of $117 with free U.S. shipping; and a six-bottle package (180-day supply) at $33 per bottle for a total of $198 with free U.S. shipping. All purchases are a one-time charge with no subscription, auto-ship, or hidden fees.
All purchases are backed by a 180-day no-questions-asked money-back guarantee. Product support is available at the Zenith Labs contact portal or by telephone at +1 (800) 928-1184. Zenith Labs is located at 19655 E 35th Dr, Suite 100, Aurora, CO 80011.
Quality and Manufacturing
Vision 20 is manufactured in an FDA-registered, GMP-certified facility in the United States. Under 21 CFR Part 111, the manufacturer is required to comply with current Good Manufacturing Practice regulations covering production standards, ingredient testing, quality control, and accurate product labeling. The manufacturing facility is regularly audited for safety and purity. All ten active ingredients are individually identified on the product’s Supplement Facts panel. The formula is gluten-free and certified non-GMO.
Usage Guidance
Vision 20 is intended for adult use as a daily vision support dietary supplement. The recommended serving is one capsule per day, taken with or without food at any time of day. Individuals who are pregnant, nursing, taking prescription medications, or managing existing medical conditions should consult a qualified healthcare professional before use. Individual results may vary.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.
Affiliate Disclosure: This press release may contain links to retail partner websites through which the distributor may receive compensation if a purchase is made following a referral. This disclosure is made in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). The existence of this affiliate relationship does not influence the factual content of this press release.
About Zenith Labs
Zenith Labs is a dietary supplement company based in Aurora, Colorado, formulating research-backed health supplements under the direction of Dr. Ryan Shelton, NMD, Director of Research. Vision 20 is a ten-ingredient carotenoid and antioxidant vision support capsule supplement combining Lutein, Zeaxanthin, Zinc, Beta-Carotene, Lycopene, Rose Hips, Vitamin A Retinyl Palmitate, Taurine, Grape Seed Extract, and Bilberry Extract, manufactured in an FDA-registered, GMP-certified U.S. facility with a 180-day satisfaction guarantee. For more information, visit bestvisionsupport.com.
Media Contact
Dr. Ryan Shelton, NMD
Director of Research, Zenith Labs
19655 E 35th Dr, Suite 100, Aurora, CO 80011
+1 (800) 928-1184
Author: Dr. Ryan Shelton, NMD, Zenith Labs — @ZenithLabs
Company: @ZenithLabs
Distributed By: XPR Media — @XPR_Syndicate
The post Vision 20 Reviews: Ten-Ingredient Carotenoid and Antioxidant Supplement by Zenith Labs Enters Commercial Market appeared first on 24 Health Times.
